Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sinarmas Multiartha Tbk. (SMMA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sinarmas Multiartha Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sinarmas Multiartha Tbk. diperdagangkan di Rp20.025 (kapitalisasi pasar 127,51 T, volume 24 jam 300). Perbedaan utamanya: Sinarmas Multiartha Tbk. jauh lebih besar — sekitar 1221,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMMA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 127,51 T |
Volume | — | 300 |
Lot | — | 3 |
Perputaran | — | 6 jt |
Harga Rata-rata | — | 20.008,33 |
Nilai Transaksi | — | 6 jt |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sinarmas Multiartha Tbk.
PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Selengkapnya di halaman SMMA →
